The Metabolic Syndrome is Associated with Circulating Adipokines in Older Adults Across a Wide Range of Adiposity

Overview

Journal J Gerontol A Biol Sci Med Sci

Specialty Geriatrics

Date 2008 Apr 23

PMID 18426966

Citations 49

Authors

Tongjian You

Barbara J Nicklas

Jingzhong Ding

Brenda W J H Penninx

Bret H Goodpaster

Douglas C Bauer

Frances A Tylavsky

Tamara B Harris

Stephen B Kritchevsky

Affiliations

Soon will be listed here.

Abstract

Background: Circulating levels of adipokines are elevated with adiposity and are closely linked with the clustering of traditional metabolic risk factors for cardiovascular disease. The purpose of this study was to examine the relationship of metabolic syndrome to several adipokines and the role of total and visceral adiposity in influencing this relationship in older adults.

Methods: A cross-sectional analysis was conducted including 1914 individuals aged 70-79 years without cardiovascular disease or type 2 diabetes. The metabolic syndrome was defined by the updated Adult Treatment Panel III criteria. Circulating levels of leptin, adiponectin, plasminogen activator inhibitor type 1 (PAI-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP) were measured. Body composition and abdominal visceral fat area were determined.

Results: Both the presence of metabolic syndrome and the number of metabolic syndrome components were associated with higher levels of leptin, PAI-1, IL-6, TNF-alpha, and CRP and with lower levels of adiponectin (all p <.0001). The odds ratios for the prevalence of metabolic syndrome associated with adipokines were attenuated after adjustment for total fat mass and/or visceral fat area, but remained significant. Levels of leptin, PAI-1, IL-6, and TNF-alpha were higher (all p <.05 to p <.0001), and adiponectin was lower (all p <.0001), in persons with, compared to those without, metabolic syndrome within each tertile of percent body fat.

Conclusion: The metabolic syndrome is associated with adipokines in older adults across a wide range of adiposity, including in those with low or normal overall fatness.

Citing Articles

Association of Adipokines and CIMT in Metabolic Syndrome in Western Uttar Pradesh Population: a Cross-Sectional Study.

Singh R, Chauhan K, Tripathi A, Choudhary R Maedica (Bucur). 2024; 19(3):494-501.

PMID: 39553344 PMC: 11565138. DOI: 10.26574/maedica.2024.19.3.494.

Obesity and Depression: Common Link and Possible Targets.

Jitte S, Keluth S, Bisht P, Wal P, Singh S, Murti K CNS Neurol Disord Drug Targets. 2024; 23(12):1425-1449.

PMID: 38747226 DOI: 10.2174/0118715273291985240430074053.

Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies.

Das D, Shruthi N, Banerjee A, Jothimani G, Duttaroy A, Pathak S Front Nutr. 2023; 10:1221438.

PMID: 37614749 PMC: 10442661. DOI: 10.3389/fnut.2023.1221438.

Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-to-45-Year-Old Females: A Cross-Sectional Study.

Sebekova K, Staruchova M, Mislanova C, Liskova A, Horvathova M, Tulinska J Antioxidants (Basel). 2023; 12(6).

PMID: 37371951 PMC: 10295263. DOI: 10.3390/antiox12061221.

Impact of Two Types of Exercise Interventions on Leptin and Omentin Concentrations and Indicators of Lipid and Carbohydrate Metabolism in Males with Metabolic Syndrome.

Makiel K, Suder A, Targosz A, Maciejczyk M, Koziol-Kozakowska A, Haim A J Clin Med. 2023; 12(8).

PMID: 37109160 PMC: 10144374. DOI: 10.3390/jcm12082822.

References

Rutter M, Meigs J, Sullivan L, DAgostino Sr R, Wilson P . C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004; 110(4):380-5. DOI: 10.1161/01.CIR.0000136581.59584.0E. View

Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S . Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol. 2006; 26(4):871-6. DOI: 10.1161/01.ATV.0000208363.85388.8f. View

Bahia L, Aguiar L, Villela N, Bottino D, Godoy-Matos A, Geloneze B . Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics (Sao Paulo). 2006; 61(5):433-40. DOI: 10.1590/s1807-59322006000500010. View

You T, Yang R, Lyles M, Gong D, Nicklas B . Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab. 2004; 288(4):E741-7. DOI: 10.1152/ajpendo.00419.2004. View

Choi K, Ryu O, Lee K, Kim H, Seo J, Kim S . Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract. 2006; 75(2):235-40. DOI: 10.1016/j.diabres.2006.06.019. View

Brochu M, Tchernof A, Dionne I, Sites C, Eltabbakh G, SIMS E . What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?. J Clin Endocrinol Metab. 2001; 86(3):1020-5. DOI: 10.1210/jcem.86.3.7365. View

Rexrode K, Pradhan A, Manson J, Buring J, Ridker P . Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol. 2003; 13(10):674-82. DOI: 10.1016/s1047-2797(03)00053-x. View

Ridker P, Buring J, Cook N, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107(3):391-7. DOI: 10.1161/01.cir.0000055014.62083.05. View

Friedman J, Halaas J . Leptin and the regulation of body weight in mammals. Nature. 1998; 395(6704):763-70. DOI: 10.1038/27376. View

10.

Roberts C, Won D, Pruthi S, Kurtovic S, Sindhu R, Vaziri N . Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol (1985). 2005; 100(5):1657-65. DOI: 10.1152/japplphysiol.01292.2005. View

11.

Kahn S, Zinman B, Haffner S, ONeill M, Kravitz B, Yu D . Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes. 2006; 55(8):2357-64. DOI: 10.2337/db06-0116. View

12.

Fried S, Bunkin D, Greenberg A . Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998; 83(3):847-50. DOI: 10.1210/jcem.83.3.4660. View

13.

Panagiotakos D, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C . The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis. 2005; 183(2):308-15. DOI: 10.1016/j.atherosclerosis.2005.03.010. View

14.

Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P . Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004; 110(12):1564-71. DOI: 10.1161/01.CIR.0000142055.53122.FA. View

15.

Alessi M, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I . Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes. 1997; 46(5):860-7. DOI: 10.2337/diab.46.5.860. View

16.

Reilly M, Rader D . The metabolic syndrome: more than the sum of its parts?. Circulation. 2003; 108(13):1546-51. DOI: 10.1161/01.CIR.0000088846.10655.E0. View

17.

Turkoglu C, Susleyici Duman B, Gunay D, Cagatay P, Ozcan R, Sevim Buyukdevrim A . Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obes Surg. 2003; 13(5):699-705. DOI: 10.1381/096089203322509255. View

18.

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-8. DOI: 10.1161/01.CIR.0000111245.75752.C6. View

19.

Han T, Williams K, Sattar N, Hunt K, Lean M, Haffner S . Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res. 2002; 10(9):923-31. DOI: 10.1038/oby.2002.126. View

20.

Lihn A, Bruun J, He G, Pedersen S, Jensen P, Richelsen B . Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol. 2004; 219(1-2):9-15. DOI: 10.1016/j.mce.2004.03.002. View